美国 · 平台与数据 · TradingView
Johnson & Johnson looking to buy Ollin Biosciences for up to $3.4 billion, FT says

详细摘要
Johnson & Johnson NYSE:JNJ is poised to buy privately held eye disease drug developer Ollin Biosciences for up to $3.4 billion, the Financial Times reported on Sunday, citing people familiar with the matter.Under the terms of the deal being discussed, J&J could pay Ollin’s backers $2.2 billion upfr…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.tradingview.com)




